Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management

21 Oct 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Ferroptosis and cancer prognosis
Share to Lung Cancer Treatments and Mutations

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37866667
DOI: 10.1016/j.cellsig.2023.110932

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer managementPMID 37866667Read ↗

Exploring AI tools and multi-omics for precision medicine in lung cancer therapy.Semantic proximity Read ↗

Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity Read ↗

Recent Advances in Personalized Lung Cancer MedicineSemantic proximity Read ↗

High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applicationsSemantic proximity Read ↗

Molecular Analysis-Based Treatment Strategies for the Management of Non-small Cell Lung CancerSemantic proximity Read ↗

Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to TherapySemantic proximity Read ↗

Application of clinical bioinformatics in lung cancer-specific biomarkersSemantic proximity Read ↗

Machine learning-based proteogenomic data modeling identifies circulating plasma biomarkers for early detection of lung cancerSemantic proximity Read ↗

The evolving paradigm of precision medicine in lung cancer.Semantic proximity Read ↗

Genetic Blueprints in Lung Cancer: Foundations for Targeted TherapiesSemantic proximity Read ↗

Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceSemantic proximity Read ↗

The molecular approach to diagnosis in lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.